Literature DB >> 8394748

Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature.

Y S Kim1, H Hollander.   

Abstract

Neurological syndromes attributed to cytomegalovirus (CMV) in patients infected with human immunodeficiency virus (HIV) include encephalitis, myelitis, and peripheral neuropathy. More recently, polyradiculopathy due to CMV has been described. We review the literature and describe two patients with CMV polyradiculopathy whose conditions improved only after prolonged therapy with ganciclovir. Patients typically are young men who are severely immunocompromised and have had other opportunistic infections. The syndrome is characterized by subacute onset of leg weakness and numbness progressing to paraparesis or paraplegia. Bladder dysfunction is common. In many patients, CMV may be identified elsewhere; concomitant retinitis is common and often subclinical. Laboratory studies commonly show an increased number of neutrophils in CSF and hypoglycorrhachia. Electromyography and nerve conduction studies support the diagnosis. Imaging studies may be most useful to exclude spinal lesions. Without treatment prognosis is poor. Survival time is improved and symptoms often abate, sometimes dramatically, with ganciclovir therapy. Improvement of conditions may be rapid but can take months, as illustrated by these two cases. Once initiated, ganciclovir should be administered indefinitely to patients with CMV polyradiculopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394748     DOI: 10.1093/clinids/17.1.32

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Cytomegalovirus polyradiculopathy in HIV-infected patients.

Authors:  P A Meier; K T Stephan; S P Blatt
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

2.  Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients.

Authors:  R F Miller; J D Fox; P Thomas; J C Waite; Y Sharvell; B G Gazzard; M J Harrison; N S Brink
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 3.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

Review 4.  Cytomegalovirus polyradiculopathy treated successfully with foscarnet.

Authors:  I Corral; C Quereda; J Cobo; J L Casado; A Guerrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

5.  Peripheral nervous system manifestations of infectious diseases.

Authors:  Kate T Brizzi; Jennifer L Lyons
Journal:  Neurohospitalist       Date:  2014-10

6.  Human immunodeficiency virus and the peripheral nerves.

Authors:  D K Ziegler
Journal:  West J Med       Date:  1994-05

Review 7.  HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment.

Authors:  E A Wulff; A K Wang; D M Simpson
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

Review 8.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

9.  Cytomegalovirus Disease in the Highly Active Antiretroviral Therapy Era.

Authors:  William Lawrence Drew
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

10.  Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients.

Authors:  D Francisci; A Tosti; R Preziosi; F Baldelli; G Stagni; S Pauluzzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.